Market Tracker

10/22 6:05pm ET

Exelixis Inc (NASDAQ:EXEL)

During the Trading Day
1.59 -0.01 / -0.63%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.59 0.00 / 0.00%
 
Volume: 6.8K

Today’s Trading

Previous close1.60
Today’s open1.60
Day’s range1.57 - 1.62
Volume1,280,920
Average volume (3 months)4,403,135
Market cap$312.2M
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-44.57%
Earnings growth (this year)-10.74%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-33.96%
P/E ratioNM
Price/Sales36.00
Price/Book4.46

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Research C...-0.05-0.74%
FLXNFlexion Therapeutics...+0.65+3.99%
BSTCBiospecifics Technol...+0.96+2.52%
ENZEnzo Biochem Inc-0.09-1.84%
Data as of 4:00pm ET, 10/22/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$31.3M
Annual profit (last year)-$244.8M
Net profit margin-781.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, Senior VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts